Special stains in liver pathology

Similar documents
Special stains in liver pathology

2014 CURRENT ISSUES IN PATHOLOGY

PITFALLS IN THE DIAGNOSIS OF MEDICAL LIVER DISEASE WITH TWO CONCURRENT ETIOLOGIES I HAVE NOTHING TO DISCLOSE CURRENT ISSUES IN ANATOMIC PATHOLOGY 2017

Basic patterns of liver damage what information can a liver biopsy provide and what clinical information does the pathologist need?

Basic patterns of liver damage what information can a liver biopsy provide and what clinical information does the pathologist need?

Pitfalls in the diagnosis of well-differentiated hepatocellular lesions

Slide 7 demonstrates acute pericholangitisis with neutrophils around proliferating bile ducts.

Autoimmune Hepatitis: Histopathology

Metabolic Liver Disease

Linda Ferrell, MD Distinguished Professor Vice Chair Director of Surgical Pathology Dept of Pathology

Autoimmune Liver Diseases

How to Approach a Medical Liver Biopsy. 9 th Bryan Warren School of Pathology Pancreatic and Liver Pathology. Sarajevo, 6 th -7 th November 2015

Dhanpat Jain Yale University School of Medicine, New Haven, CT

Liver Pathology Symposium - medical livers

Hereditary Haemochromatosis (A pint too many: discussing haemochromatosis) John Lee

Hemosiderin. Livia Vida 2018

Steatosis/Steatohepatitis

Role of Liver Biopsy. Role of Liver Biopsy 9/3/2009. Liver Biopsies in Viral Hepatitis: Beyond Grading and Staging

-sheet 3. -Waseem Alhaj. Maha Shomaf

Liver Pathology in the 0bese

DILI PATHOLOGY. PHILIP KAYE November 2017 BSG Pathology Winter Meeting

Fat, ballooning, plasma cells and a +ANA. Yikes! USCAP 2016 Evening Specialty Conference Cynthia Guy

Case n 1 ( B 92 / 4208 ) Case n 2 ( B 00 / 8249 ) Case n 3 ( B 98 / 8352 )

Hepatocytes produce. Proteins Clotting factors Hormones. Bile Flow

National Liver EQA Scheme. Open meeting, Glasgow March 24th 2004

Nottingham Patterns of liver fibrosis and their clinical significance

Atlas of Stains. Special Stains on Artisan Link Pro

Disclosures Drug-induced Acute Liver Failure

Adults with Inherited Liver Diseases

Chronic Biliary Disease. Dr Susan Davies & Dr Bill Griffiths

General Guidelines for Health professionals

Biliary tract diseases of the liver

Liver National EQA Scheme. Circulation Q Birmingham, March 15 th 2005

Non-Cirrhotic Portal Hypertension and Incomplete Septal Cirrhosis. Stefan Hübscher, University of Birmingham, Birmingham B15 2TT, U.K.

Metabolic Liver Diseases

Diseases of liver. Dr. Mohamed. A. Mahdi 4/2/2019. Mob:

Metabolic Liver Disease: What s New in Diagnosis and Therapy?

Liver and gall bladder curriculum for ST1, presented at Northern block teaching, January 2017.

Hereditary Hemochromatosis: What Have We Learnt from Population Studies Professor John K. Olynyk

I have no disclosures relevant to this presentation LIVER TESTS: WHAT IS INCLUDED? LIVER TESTS: HOW TO UTILIZE THEM OBJECTIVES

Presented by: Dr. Giuseppe Molinaro Dr. Davide De Biase

Preface 1. Fixation and Processing 1

Value of copper-associated protein in diagnostic assessment of liver biopsy

Liver Specialty Evening Conference. Matthew M. Yeh, MD, PhD Professor of Pathology Adjunct Professor of Medicine University of Washington, Seattle

PATHOPHYSIOLOGY. DEFINED Involves the study of function that results from disease processes.

AMR in Liver Transplantation: Incidence

Natural history of α-1-atd in children

AASLD: Boston Rob Goldin

Acute and Chronic Hepatitis John Hart, M.D. University of Chicago Medical Center

Cirrhosis is different from Fibrosis

Evaluation of Liver Mass Lesions. American College of Gastroenterology 2013 Regional Postgraduate Course

Relationship between Serum Iron Indices and Hepatic Iron Quantitation in Patients with Fatty Liver Disease

Update on Nonalcoholic Fatty Liver Disease. Kathleen E Corey, MD, MPH, MMSc Director, Mass General Fatty Liver Clinic

Steatotic liver disease

British Liver Transplant Group Pathology meeting September Leeds cases

Cell injury, adaptation and death. Unite one Second Lab.

A Review of Liver Function Tests. James Gray Gastroenterology Vancouver

Liver Pathology: Cirrhosis, Hepatitis, and Primary Liver Tumors. Update and Diagnostic Problems

21/07/2017. Update on Autoimmune Biliary Disease. Changing Role of Liver Biopsy in PBC and PSC. Primary Biliary Cirrhosis Cholangitis

LIVER PATHOLOGY. Thursday 28 th November 2013

PATHOLOGY OF LIVER TUMORS

9/28/2016. Elevated Liver Function Tests: A Case Based Approach. Objectives. Identify patterns of abnormal liver function tests

Viral Hepatitis (I) Luigi Terracciano Department of Pathology University Hospital Basel. Basel,

NONALCOHOLIC FATTY LIVER DISEASE. Non-Alcoholic Fatty Liver Disease (NAFLD) Primary NAFLD. April 13, 2012

Update on Autoimmune Liver Disease. Role of Liver Biopsy in Autoimmune Hepatitis, PBC and PSC

ACP-BSG meeting The liver in systemic inflammatory disorders. Dr Adrian C Bateman Southampton University Hospitals NHS Trust

Corporate Medical Policy Genetic Testing for Hereditary Hemochromatosis

The problem with pumping too much iron

Introduction 5/2/2013 IRON RELATED GENES AND OXIDATIVE STRESS IN NON- ALCOHOLIC STEATOHEPATITIS. Iron Physiology. Iron Physiology

There is extensive literature addressing both the histopathologic

Metabolic liver disease

Invited Re vie W. Analytical histopathological diagnosis of small hepatocellular nodules in chronic liver diseases

PBC and PSC: Back to Basics

Challenges in the Diagnosis of Steatohepatitis

Autoimmune hepatitis

Histology. The pathology of the. bile ducts. pancreas. liver. The lecture in summary. Vt-2006

Iron overload syndromes and the liver

Hereditary Haemochromatosis For GPs

Liver Transplant Pathology a general view

O Farrell Legacy UPDATE ON WHO NOMENCLATURE. World Health Organization, 2010 DISCLOSURES WITH EMPHASIS ON PROBLEM HEPATOCELLULAR TUMORS

A Systematic Approach to Medical Liver Disease

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Hepatopathology for Gastroenterologists and Hepatologists

What Is Cirrhosis? CIRRHOSIS. Cirrhosis occurs when the liver is. by chronic conditions and diseases. permanently scarred or injured

When is immunohistochemistry useful in adult medical liver disease? Chris Bellamy Edinburgh

Circulation T. Manchester July 5 th 2006

Noncirrhotic Portal Hypertension and Pathology of the Sinusoids. Ian R. Wanless Department of Pathology Dalhousie University Halifax, Canada

TOO MUCH OF A GOOD THING: DIAGNOSIS & MANAGEMENT OF HEREDITARY HEMOCHROMATOSIS MARY JO DREW, MD, MHSA TRANSFUSION MEDICINE CONSULTANT

Pathological Classification of Hepatocellular Carcinoma

AAIM: GI Workshop Follow Up to Case Studies. Non-alcoholic Fatty Liver Disease Ulcerative Colitis Crohn s Disease

Mesenchymal Tumors. Cavernous Hemangioma (CH) VASCULAR TUMORS MESENCHYMAL TUMORS OF THE LIVER: WHAT S NEW AND UNUSUAL (MY PERSPECTIVE)

CASE 1 Plasma Cell Infiltrates: Significance in post liver transplantation and in chronic liver disease

Liver Cancer Causes, Risk Factors, and Prevention

CHAPTER 1. Alcoholic Liver Disease

The Oral Histology Series Series 5 Special Stains

LIVER DISEASES. Pathology Department, Zhejiang University School of Medicine,

Liver Network. Guidelines for the Management of Adults with Asymptomatic Liver Function Abnormalities

Liver, Pancreas and Gall Bladder Pathology

Metabolic, Miscellaneous and Inflammatory Diseases of the Liver. 1. A 50 year old man is seen in the office for routine evaluation.

Chapter 18 LIVER BILIARY TRACT

Transcription:

Current Issues in Surgical Pathology 2014 Special stains in liver pathology Which, why, how Really? Sanjay Kakar, MD University of California, San Francisco Outline Which stains Why the stain is done How the stain is interpreted Pitfalls, technical aspects Really Reflex use of special stains Special stains: liver pathology Trichrome Iron PAS-diastase Reticulin Copper Other: elastic, PAS, bile 1

Process Role Principle Iron hematoxylin Nuclear stain Red dye: Acid fuchsin (Biebrich scarlet) chromotrope 2R Polyacid (phosphotungstic acid) Blue/green dye: Methyl green Fast Green Aniline Blue Stains cytoplasm, muscle Removes red dye from collagen Stains collagen Works well in acidic solutions Intermediate molecular weight, stain both collagen and muscle Large molecules Large molecule dye: stains only collagen Masson: sequential staining, Gomori: single step Pale staining, no nuclear staining Why Trichrome stain Staging: viral hepatitis, steatohepatitis Diagnosis of steatohepatitis Regression of cirrhosis Fibrosis vs. necrosis Recognizing unsuspected amyloidosis How Interpretation and pitfalls 2

Steatohepatitis: essential features AASLD/NASH Clinical Research Network Steatosis Inflammation Hepatocellular injury Ballooned hepatocytes Pericellular fibrosis Steatosis mild inflammation Steatosis Pericellular fibrosis 3

Steatosis vs. steatohepatitis Disease progression Treatment Steatohepatitis guidelines 4

Overstained trichrome Pitfall in staging - histiocytic aggregate Chronic venous outflow obstruction 5

Trichrome stain Staging: viral hepatitis Steatohepatitis Regression of cirrhosis Fibrosis vs. necrosis Cirrhosis regression Thin fibrous septa with perforations Prominent vessels and ductular reaction disappear Nodularity may persist Wanless, Arch Pathol Lab Med, 2000 Friedman, Hepatology 2006 Chang, Hepatology, 2010 Alcoholic cirrhosis with regression 6

Thin septa: no shunting vessels or ductular reaction Regression: perforated fibrous septa 42 M with jaundice,hepatomegaly x 4 wks ALT, AST >1000 U/L Ultrasound: cirrhosis 7

Repeat trichrome Dark: portal collagen, Light: necrosis Orcein stain: no elastic fibers in necrotic area 8

Amyloid: pale deposits Globular amyloid deposits: subtle on HE stain Globular amyloid: highlighted by trichrome 9

Special stains: liver pathology Trichrome Iron PAS-diastase Reticulin Copper Other: elastic, PAS, bile Perls iron stain (not Perl s) K ferrocyanide + HCl Ferric ferrocyanide (Prussian blue) Max Perls: German pathologist Why Iron stain Distinguish from other pigments Semiquantitative analysis How Patterns of hepatic iron overload Grading of iron overload 10

Normal iron regulation Hepcidin Activity depends on iron stores Binds ferroportin Fig: Textbook of Liver Pathology: Kakar, Ferrell, Eds. Chapter by M Torbenson Genetic/acquired Hepcidin Ferroportin Transferrin Increased iron Dietary Hemolysis Fig: Textbook of Liver Pathology: Kakar, Ferrell, Eds. Chapter by M Torbenson 11

Primary HFE hemochromatosis Non-HFE hemochromatosis Pattern of siderosis Mechanism Hepatocellular Starts periportal Mostly hepatocellular Some: macrophages HFE gene mutation Non-HFE mutations Secondary Hemolysis, multiple transfusions Pattern of siderosis Mechanism Macrophages Excess iron from RBC Chronic diseases Macrophages Excess iron in macrophages Iron storage Storage form Ferritin Iron oxyhydroxide and apoferritin Hemosiderin Aggregates of iron oxyhydroxide crystals without apoferritin Distribution Virtually all cells Trace amounts in the plasma Reticuloendothelial system including Kupffer cells Hemosiderin Ferritin blush 12

Iron stain: interpretation Grading of iron overload Patterns of hepatic iron overload Modified Scheuer grading scheme Grade Grade 0 Grade 1 Grade 2 Grade 3 Grade 4 Definition Granules absent or barely discernible at 400x Granules discernible at 250x Granules discernible at 100x Granules discernible at 25x Masses visible at 10x or naked eye Deugner-Turlin grading scheme 13

Iron grading: simple method Grade Extent of iron Minimal <5% Mild 5-33% Moderate 34-67% Marked 68-100% Separate grade: hepatocellular, Kupffer cell Hepatocellular: periportal vs. random Iron: quantitative analysis Can be performed from paraffin embedded tissue Allows correlation with H&E morphology Normal iron Mild increase Moderate Marked 10-36 µmol/g of liver tissue Up to 150 µmol/g of liver tissue 151-300 µmol/g of liver tissue >300 µmol/g of liver tissue Hepatic iron index μg iron per gram dry weight of liver/55.846 patient's age >1.9: suggests hemochromatosis (non-cirrhotic) Iron stain: interpretation Grading of iron overload Patterns of hepatic iron overload 14

History 35/M with obesity Elevated serum ferritin Liver biopsy: steatohepatitis Periportal hepatocellular siderosis Periportal hepatocellular siderosis 15

Iron overload in NASH 20-50% serum ferritin elevated 15-60% increased hepatic iron Distribution Kupffer or hepatocellular mild/moderate, random Hepatocellular, periportal Interpretation Secondary HH or secondary Periportal siderosis HFE hemochromatosis Non-HFE hemochromatosis Secondary iron overload Steatohepatitis Rare conditions Porphyria cutanea tarda Hereditary aceruloplasminemia Diagnosis HFE 282Y homozygous Steatohepatitis HFE hemochromatosis with mild periportal hepatocellular siderosis, no portal based fibrosis Significance of iron overload or HFE mutations in progression of steatohepatitis is not clear 16

History 55/M with cirrhosis No HFE mutation No known etiology HII>2, heterogeneous iron overload Cirrhosis with siderosis Non HFE hemochromatosis Secondary siderosis in cirrhosis of another etiology 17

Type 1 (HFE HH) Type 2 (Juvenile HH) Type 3 Type 4 Hemochromatosis Genetics Liver biopsy Clinical presentation Autosomal recessive Hepatocytes 3 rd or 4 th decade C282Y homozygous, Liver, pancreas, C282Y /H63D heart, skin, joints Autosomal recessive Hemojuvelin (2A) or hepcidin (2B) Autosomal recessive Transferrin receptor type 2 mutation Autosomal dominant Ferroportin mutation Hepatocytes Hepatocytes 1 st subtype: hepatocytes 2 nd subtype: Kupffer cells 1 st three decades More severe disease than HFE HH Similar to HFE HH Intermediate between HFE HH and juvenile HH 4 th or 5 th decade Severity varies with type of mutation Siderosis in cirrhosis Ludwig, Gastroenterology, 1997 (n=447, HII>1.9) Hereditary hemochromatosis 100% Alpha-1-antitrypsin deficiency 28% Cryptogenic cirrhosis 19% Alcoholic cirrhosis 14% Chronic hepatitis B, hepatitis C 18%, 7% PBC, PSC 1% each Marked siderosis can occur in the absence of HH Siderosis rare in biliary diseases Siderosis is an adverse risk factor* *Brandhagen, Hepatology, 2000 HFE HH: Homogeneous distribution Image: Dr. Linda Ferrell 18

Siderosis: periseptal, stroma, endothelial cells Bile duct siderosis Cirrhosis: HH or secondary siderosis Hereditary hemochromatosis Homogeneous distribution Siderosis in bile ducts, stroma, endothelial cells HFE mutation (in HFE HH) Cirrhosis with marked secondary siderosis Heterogeneous Generally absent Not present Diagnosis: Cryptogenic cirrhosis with secondary iron overload 19

Collapse with ductular reaction with siderosis: often nonspecific -High grade dysplastic lesions -50% develop HCC on follow-up Image: Dr. L Ferrell Iron stain: role of the pathologist Clinical setting HFE C282Y homo C282Y/H63D HFE other mutations Interpretation Extent of iron Extent of fibrosis Extent of iron No risk for HFE HH 20

Iron stain: role of the pathologist Clinical setting HFE not known Chronic viral hepatitis Steatohepatitis Cirrhosis Interpretation Raise possibility of HH Periportal siderosis, or moderate to marked hepatocellular iron Recommend HFE testing Possible disease progression Possible poor prognosis Special stains: liver pathology Trichrome Iron PAS-diastase Reticulin Copper Other: elastic, PAS, bile PAS-diastase stain Glycogen, other carbohydrates Periodic acid converts OH component to aldehyde Combines with Schiff reagent: magenta complex Diastase digests glycogen 21

PAS-D stain Why Alpha-1-antitrypsin deficiency Highlight macrophages Glycogen (with PAS stain) Highlights basement membrane How Pitfalls Interpretation A1AT deficiency Mallory hyaline Giant mitochondria A1AT deficiency Giant mitochondria 22

A1AT deficiency Incomplete digestion Immunohistochemistry: alpha-1-antitrypsin 50/F with cirrhosis, obese, serum A1AT normal 23

PAS-D stain Cytoplasmic globules Alpha-1-antitrypsin deficiency Normal allele PiMM Homozygous state (PiZZ) Chronic hepatitis and cirrhosis Heterozygous state (PiMZ) Significance unclear Progression of fibrosis in other liver diseases 24

Alpha-1-antitrypsin deficiency Challenges in diagnosis (clinical) Uncommon disease Can occur in the absence of child hood symptoms and lung disease Serum levels unreliable Alpha-1-antitrypsin deficiency Challenges in diagnosis (pathologic) Cytoplasmic globules can be subtle PAS-D: periportal location Globules not specific for diagnosis Vascular etiologies Acute hepatitis PiZZ vs. PiMZ cannot be distinguished on biopsy Homozygous (PiZZ) Heterozygous (PiMZ) Gold standard for diagnosis: Protease inhibitor phenotyping 25

Mild portal inflammation Resolving hepatitis: PAS-D stain highlights macrophages Fig 7.3 History 40/M with renal transplant Persistent elevation of ALT, AST 5-6x No history of viral hepatitis 26

Cytoplasmic inclusions Ground glass appearance Hepatitis B Drugs: Barbiturates, cyanamide Metabolic diseases Glycogen storage IV Lafora disease Hypo(a)fibrinogenemia Wisell, AJSP, 2006; Bejarano, Virchow Arch, 2006 Glycogen inclusions ( pseudo ground glass ) Often on multiple immunosuppressive medications No correlation with any specific drug Wisell, AJSP, 2006; Bejarano, Virchow Arch, 2006 27

PAS-D stain: partial digestion Special stains: liver pathology Trichrome Iron PAS-diastase Reticulin Copper Other: elastic, PAS, bile Reticulin stain Argylophilic reaction Sensitization: heavy metals Ammoniacal silver Reducing agent (formaldehyde) Toning: gold Removal of unreacted silver 28

Reticulin stain Why Collapse of reticulin fibers: necrosis Nodular liver architecture (NRH) Abnormal reticulin network (HCC) How Interpretation Pitfalls History 60/F with long history of rheumatoid arthritis Portal hypertension Ultrasound: cirrhosis Biopsy Normal portal tracts Hepatocellular damage: none No inflammation No fibrosis 29

Nodular architecture: reticulin Nodular regenerative hyperplasia Wanless criteria Hepatocellular nodules, often <0.3 cm Often diffuse involvement of the liver Fibrosis absent or minimal Wanless IR, Hepatology, 1990 Nodular regenerative hyperplasia 30

Reticulin: inadequately stained Regenerative area Special stains: liver pathology Trichrome Iron PAS-diastase Reticulin Copper Other: elastic, PAS, bile 31

Why Copper stain Chronic biliary disease Wilson disease: not reliable How Interpretation Pitfalls Copper stain Orcein: black granules Rubeanic acid: black granules Rhodanine: red granules Rubeanic acid: copper in periportal hepatocytes 32

40/F with positive ANA, SMA Biopsy diagnosis of AIH Clinical picture and liver enzymes favored biliary disease Hepatocellular injury mild, bile duct damage can be patchy Periportal copper Periportal CK7+ Autoimmune cholangiopathy (AMA-negative PBC) 33

Copper stain Hepatitic vs. biliary etiology not clear Careful review in periportal region Conjunction with CK7 Not useful in advanced disease Negative results do not exclude biliary disease Wilson disease: quantitative copper reliable Really Survey Which stain(s) should be performed up front for every liver biopsy? Trichrome PAS-D Iron Retic Copper N=15 100% 40% 40% 20% 0 Univ 100% 60% 60% 30% 0 (n=10) UCSF (n=5) 100% 40% 20% 0 0 PAS-D: Globules of A1AT Iron: Mild periportal siderosis in early HH 34

Mean stage 1.0 with H&E, 1.69 with trichrome Trichrome stage was higher in 53.3% Fibrosis stage was raised by 2 or more points in 17.8% with trichrome stain The hepatic fibrosis score is significantly underestimated by H&E stain in the posttransplant setting in hepatitis C 35